메뉴 건너뛰기




Volumn 5, Issue 2, 2013, Pages 676-713

Epigenetics and colorectal cancer pathogenesis

Author keywords

Colorectal cancer; DNMT; Epigenetic therapy; HDAC; HMTase

Indexed keywords

DNA METHYLTRANSFERASE; DNA METHYLTRANSFERASE INHIBITOR; FLUOROPYRIMIDINE; FLUOROURACIL; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; HISTONE DEMETHYLASE; HISTONE METHYLTRANSFERASE; METHYLTRANSFERASE INHIBITOR; MICRORNA; MICRORNA 126; MICRORNA 133B; MICRORNA 135A; MICRORNA 135B; MICRORNA 139; MICRORNA 141; MICRORNA 143; MICRORNA 145; MICRORNA 17; MICRORNA 18A; MICRORNA 192; MICRORNA 200A; MICRORNA 200B; MICRORNA 200C; MICRORNA 21; MICRORNA 34A; MICRORNA 92; UNCLASSIFIED DRUG; UNINDEXED DRUG; VORINOSTAT;

EID: 84878822005     PISSN: None     EISSN: 20726694     Source Type: Journal    
DOI: 10.3390/cancers5020676     Document Type: Article
Times cited : (202)

References (269)
  • 2
    • 35348992639 scopus 로고    scopus 로고
    • The genetics of hereditary colon cancer
    • Rustgi, A.K. The genetics of hereditary colon cancer. Genes Dev. 2007, 21, 2525-2538.
    • (2007) Genes Dev. , vol.21 , pp. 2525-2538
    • Rustgi, A.K.1
  • 5
    • 0038587747 scopus 로고    scopus 로고
    • The two faces of IKK and NF-kappaB inhibition: Prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion
    • Chen, L.W.; Egan, L.; Li, Z.W.; Greten, F.R.; Kagnoff, M.F.; Karin, M. The two faces of IKK and NF-kappaB inhibition: Prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion. Nat. Med. 2003, 9, 575-581.
    • (2003) Nat. Med. , vol.9 , pp. 575-581
    • Chen, L.W.1    Egan, L.2    Li, Z.W.3    Greten, F.R.4    Kagnoff, M.F.5    Karin, M.6
  • 7
    • 67650330166 scopus 로고    scopus 로고
    • Carcinogenesis in IBD: Potential targets for the prevention of colorectal cancer
    • Feagins, L.A.; Souza, R.F.; Spechler, S.J. Carcinogenesis in IBD: Potential targets for the prevention of colorectal cancer. Nat. Rev. Gastroenterol. Hepatol. 2009, 6, 297-305.
    • (2009) Nat. Rev. Gastroenterol. Hepatol. , vol.6 , pp. 297-305
    • Feagins, L.A.1    Souza, R.F.2    Spechler, S.J.3
  • 8
    • 0031972522 scopus 로고    scopus 로고
    • Cancer cells exhibit a mutator phenotype
    • Loeb, L.A. Cancer cells exhibit a mutator phenotype. Adv. Cancer Res. 1998, 72, 25-56.
    • (1998) Adv. Cancer Res. , vol.72 , pp. 25-56
    • Loeb, L.A.1
  • 9
    • 0030852491 scopus 로고    scopus 로고
    • Foulds' dangerous idea revisited: The multistep development of tumors 40 years later
    • Klein, G. Foulds' dangerous idea revisited: The multistep development of tumors 40 years later. Adv. Cancer Res. 1998, 72, 1-23.
    • (1998) Adv. Cancer Res. , vol.72 , pp. 1-23
    • Klein, G.1
  • 10
    • 0025312728 scopus 로고
    • A genetic model for colorectal tumorigenesis
    • Fearon, E.R.; Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell 1990, 61, 759-767.
    • (1990) Cell , vol.61 , pp. 759-767
    • Fearon, E.R.1    Vogelstein, B.2
  • 11
    • 0030592517 scopus 로고    scopus 로고
    • Lessons from hereditary colorectal cancer
    • Kinzler, K.W.; Vogelstein, B. Lessons from hereditary colorectal cancer. Cell 1996, 87, 159-170.
    • (1996) Cell , vol.87 , pp. 159-170
    • Kinzler, K.W.1    Vogelstein, B.2
  • 12
    • 30644459835 scopus 로고    scopus 로고
    • Serrated pathway and APC (conventional)-type colorectal polyps: Molecular-morphologic correlations, genetic pathways, and implications for classification
    • Goldstein, N.S. Serrated pathway and APC (conventional)-type colorectal polyps: Molecular-morphologic correlations, genetic pathways, and implications for classification. Am. J. Clin. Pathol. 2006, 125, 146-153.
    • (2006) Am. J. Clin. Pathol. , vol.125 , pp. 146-153
    • Goldstein, N.S.1
  • 13
    • 0034626769 scopus 로고    scopus 로고
    • The age of cancer
    • DePinho, R.A. The age of cancer. Nature 2000, 408, 248-254.
    • (2000) Nature , vol.408 , pp. 248-254
    • DePinho, R.A.1
  • 14
    • 66149095468 scopus 로고    scopus 로고
    • Serrated polyps and colorectal cancer: New pathway to malignancy
    • Noffsinger, A.E. Serrated polyps and colorectal cancer: New pathway to malignancy. Annu. Rev. Pathol. 2009, 4, 343-364.
    • (2009) Annu. Rev. Pathol. , vol.4 , pp. 343-364
    • Noffsinger, A.E.1
  • 21
    • 36649005377 scopus 로고    scopus 로고
    • Molecular heterogeneity of colorectal cancer: Implications for cancer control
    • Jass, J.R. Molecular heterogeneity of colorectal cancer: Implications for cancer control. Surg. Oncol. 2007, 16, S7-S9.
    • (2007) Surg. Oncol. , vol.16
    • Jass, J.R.1
  • 23
  • 24
    • 0034785348 scopus 로고    scopus 로고
    • TGF-beta signaling in tumor suppression and cancer progression
    • Derynck, R.; Akhurst, R.J.; Balmain, A. TGF-beta signaling in tumor suppression and cancer progression. Nat. Genet. 2001, 29, 117-129.
    • (2001) Nat. Genet. , vol.29 , pp. 117-129
    • Derynck, R.1    Akhurst, R.J.2    Balmain, A.3
  • 25
    • 16044369574 scopus 로고    scopus 로고
    • MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma
    • Eppert, K.; Scherer, S.W.; Ozcelik, H.; Pirone, R.; Hoodless, P.; Kim, H.; Tsui, L.C.; Bapat, B.; Gallinger, S.; Andrulis, I.L.; et al. MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 1996, 86, 543-552.
    • (1996) Cell , vol.86 , pp. 543-552
    • Eppert, K.1    Scherer, S.W.2    Ozcelik, H.3    Pirone, R.4    Hoodless, P.5    Kim, H.6    Tsui, L.C.7    Bapat, B.8    Gallinger, S.9    Andrulis, I.L.10
  • 26
    • 0032489508 scopus 로고    scopus 로고
    • Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes
    • Takaku, K.; Oshima, M.; Miyoshi, H.; Matsui, M.; Seldin, M.F.; Taketo, M.M. Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes. Cell 1998, 92, 645-656.
    • (1998) Cell , vol.92 , pp. 645-656
    • Takaku, K.1    Oshima, M.2    Miyoshi, H.3    Matsui, M.4    Seldin, M.F.5    Taketo, M.M.6
  • 27
    • 79751489596 scopus 로고    scopus 로고
    • Molecular genetics of colorectal cancer
    • Fearon, E.R. Molecular genetics of colorectal cancer. Annu. Rev. Pathol. 2011, 6, 479-507.
    • (2011) Annu. Rev. Pathol. , vol.6 , pp. 479-507
    • Fearon, E.R.1
  • 35
    • 72449176846 scopus 로고    scopus 로고
    • Molecular origins of cancer: Molecular basis of colorectal cancer
    • Markowitz, S.D.; Bertagnolli, M.M. Molecular origins of cancer: Molecular basis of colorectal cancer. N. Engl. J. Med. 2009, 361, 2449-2460.
    • (2009) N. Engl. J. Med. , vol.361 , pp. 2449-2460
    • Markowitz, S.D.1    Bertagnolli, M.M.2
  • 36
    • 78651241644 scopus 로고    scopus 로고
    • Colorectal cancer molecular biology moves into clinical practice
    • Pritchard, C.C.; Grady, W.M. Colorectal cancer molecular biology moves into clinical practice. Gut 2011, 60, 116-129.
    • (2011) Gut , vol.60 , pp. 116-129
    • Pritchard, C.C.1    Grady, W.M.2
  • 37
    • 77449130761 scopus 로고    scopus 로고
    • Microsatellite instability in colorectal cancer
    • Boland, C.R.; Goel, A. Microsatellite instability in colorectal cancer. Gastroenterology 2010, 138, 2073-2087. e3.
    • (2010) Gastroenterology , vol.138
    • Boland, C.R.1    Goel, A.2
  • 40
    • 80052926952 scopus 로고    scopus 로고
    • Comprehensive analysis of CpG island methylator phenotype (CIMP)-high,-low, and-negative colorectal cancers based on protein marker expression and molecular features
    • Zlobec, I.; Bihl, M.; Foerster, A.; Rufle, A.; Lugli, A. Comprehensive analysis of CpG island methylator phenotype (CIMP)-high,-low, and-negative colorectal cancers based on protein marker expression and molecular features. J. Pathol. 2011, 225, 336-343.
    • (2011) J. Pathol. , vol.225 , pp. 336-343
    • Zlobec, I.1    Bihl, M.2    Foerster, A.3    Rufle, A.4    Lugli, A.5
  • 45
    • 79952284127 scopus 로고    scopus 로고
    • Hallmarks of cancer: The next generation
    • Hanahan, D.; Weinberg, R.A. Hallmarks of cancer: The next generation. Cell 2011, 144, 646-674.
    • (2011) Cell , vol.144 , pp. 646-674
    • Hanahan, D.1    Weinberg, R.A.2
  • 47
    • 84877136981 scopus 로고    scopus 로고
    • Lymphotoxin beta receptor mediates caspase-dependent tumor cell apoptosis in vitro and tumor suppression in vivo despite induction of NF-kappaB activation
    • PubMed ID:23349015
    • Hu, X.; Zimmerman, A.M.; Bardhan, K.; Yang, D.; Waller, J.L.; Liles, G.B.; Lee, J.R.; Pollock, R.; Lev, D.; Ware, C.F.; et al. Lymphotoxin beta receptor mediates caspase-dependent tumor cell apoptosis in vitro and tumor suppression in vivo despite induction of NF-kappaB activation. Carcinogenesis 2013, PubMed ID:23349015.
    • (2013) Carcinogenesis
    • Hu, X.1    Zimmerman, A.M.2    Bardhan, K.3    Yang, D.4    Waller, J.L.5    Liles, G.B.6    Lee, J.R.7    Pollock, R.8    Lev, D.9    Ware, C.F.10
  • 49
    • 84866381896 scopus 로고    scopus 로고
    • Unphosphorylated STAT1 promotes sarcoma development through repressing expression of Fas and bad and conferring apoptotic resistance
    • Zimmerman, M.A.; Rahman, N.T.; Yang, D.; Lahat, G.; Lazar, A.J.; Pollock, R.E.; Lev, D.; Liu, K. Unphosphorylated STAT1 promotes sarcoma development through repressing expression of Fas and bad and conferring apoptotic resistance. Cancer Res. 2012, 72, 4724-4732.
    • (2012) Cancer Res. , vol.72 , pp. 4724-4732
    • Zimmerman, M.A.1    Rahman, N.T.2    Yang, D.3    Lahat, G.4    Lazar, A.J.5    Pollock, R.E.6    Lev, D.7    Liu, K.8
  • 51
    • 33646755569 scopus 로고    scopus 로고
    • Cancer immunosurveillance and immunoediting: The roles of immunity in suppressing tumor development and shaping tumor immunogenicity
    • Smyth, M.J.; Dunn, G.P.; Schreiber, R.D. Cancer immunosurveillance and immunoediting: The roles of immunity in suppressing tumor development and shaping tumor immunogenicity. Adv. Immunol. 2006, 90, 1-50.
    • (2006) Adv. Immunol. , vol.90 , pp. 1-50
    • Smyth, M.J.1    Dunn, G.P.2    Schreiber, R.D.3
  • 58
    • 33749347023 scopus 로고    scopus 로고
    • Will Rogers revisited: Prospective observational study of survival of 3592 patients with colorectal cancer according to number of nodes examined by pathologists
    • George, S.; Primrose, J.; Talbot, R.; Smith, J.; Mullee, M.; Bailey, D.; du Boulay, C.; Jordan, H. Will Rogers revisited: Prospective observational study of survival of 3592 patients with colorectal cancer according to number of nodes examined by pathologists. Br. J. Cancer 2006, 95, 841-847.
    • (2006) Br. J. Cancer , vol.95 , pp. 841-847
    • George, S.1    Primrose, J.2    Talbot, R.3    Smith, J.4    Mullee, M.5    Bailey, D.6    du Boulay, C.7    Jordan, H.8
  • 59
    • 0036158699 scopus 로고    scopus 로고
    • Lymph node recoveries from 2427 pT3 colorectal resection specimens spanning 45 years: Recommendations for a minimum number of recovered lymph nodes based on predictive probabilities
    • Goldstein, N.S. Lymph node recoveries from 2427 pT3 colorectal resection specimens spanning 45 years: Recommendations for a minimum number of recovered lymph nodes based on predictive probabilities. Am. J. Surg. Pathol. 2002, 26, 179-189.
    • (2002) Am. J. Surg. Pathol. , vol.26 , pp. 179-189
    • Goldstein, N.S.1
  • 60
    • 0041885405 scopus 로고    scopus 로고
    • Colon cancer survival is associated with increasing number of lymph nodes analyzed: A secondary survey of intergroup trial INT-0089
    • Le Voyer, T.E.; Sigurdson, E.R.; Hanlon, A.L.; Mayer, R.J.; Macdonald, J.S.; Catalano, P.J.; Haller, D.G. Colon cancer survival is associated with increasing number of lymph nodes analyzed: A secondary survey of intergroup trial INT-0089. J. Clin. Oncol. 2003, 21, 2912-2919.
    • (2003) J. Clin. Oncol. , vol.21 , pp. 2912-2919
    • le Voyer, T.E.1    Sigurdson, E.R.2    Hanlon, A.L.3    Mayer, R.J.4    McDonald, J.S.5    Catalano, P.J.6    Haller, D.G.7
  • 62
    • 33646850390 scopus 로고    scopus 로고
    • Lymph node counts, rates of positive lymph nodes, and patient survival for colon cancer surgery in Ontario, Canada: A population-based study
    • Bui, L.; Rempel, E.; Reeson, D.; Simunovic, M. Lymph node counts, rates of positive lymph nodes, and patient survival for colon cancer surgery in Ontario, Canada: A population-based study. J. Surg. Oncol. 2006, 93, 439-445.
    • (2006) J. Surg. Oncol. , vol.93 , pp. 439-445
    • Bui, L.1    Rempel, E.2    Reeson, D.3    Simunovic, M.4
  • 63
    • 34047245618 scopus 로고    scopus 로고
    • Lymph node evaluation and survival after curative resection of colon cancer: Systematic review
    • Chang, G.J.; Rodriguez-Bigas, M.A.; Skibber, J.M.; Moyer, V.A. Lymph node evaluation and survival after curative resection of colon cancer: Systematic review. J. Natl. Cancer Inst. 2007, 99, 433-441.
    • (2007) J. Natl. Cancer Inst. , vol.99 , pp. 433-441
    • Chang, G.J.1    Rodriguez-Bigas, M.A.2    Skibber, J.M.3    Moyer, V.A.4
  • 64
    • 70350225838 scopus 로고    scopus 로고
    • Lymphocytic reaction to colorectal cancer is associated with longer survival, independent of lymph node count, microsatellite instability, and CpG island methylator phenotype
    • Ogino, S.; Nosho, K.; Irahara, N.; Meyerhardt, J.A.; Baba, Y.; Shima, K.; Glickman, J.N.; Ferrone, C.R.; Mino-Kenudson, M.; Tanaka, N.; et al. Lymphocytic reaction to colorectal cancer is associated with longer survival, independent of lymph node count, microsatellite instability, and CpG island methylator phenotype. Clin. Cancer Res. 2009, 15, 6412-6420.
    • (2009) Clin. Cancer Res. , vol.15 , pp. 6412-6420
    • Ogino, S.1    Nosho, K.2    Irahara, N.3    Meyerhardt, J.A.4    Baba, Y.5    Shima, K.6    Glickman, J.N.7    Ferrone, C.R.8    Mino-Kenudson, M.9    Tanaka, N.10
  • 67
    • 5544242524 scopus 로고    scopus 로고
    • Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis
    • Guidoboni, M.; Gafa, R.; Viel, A.; Doglioni, C.; Russo, A.; Santini, A.; Del Tin, L.; Macri, E.; Lanza, G.; Boiocchi, M.; et al. Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis. Am. J. Pathol. 2001, 159, 297-304.
    • (2001) Am. J. Pathol. , vol.159 , pp. 297-304
    • Guidoboni, M.1    Gafa, R.2    Viel, A.3    Doglioni, C.4    Russo, A.5    Santini, A.6    Del Tin, L.7    Macri, E.8    Lanza, G.9    Boiocchi, M.10
  • 69
    • 33748040054 scopus 로고    scopus 로고
    • Correlation of pathologic features with CpG island methylator phenotype (CIMP) by quantitative DNA methylation analysis in colorectal carcinoma
    • Ogino, S.; Odze, R.D.; Kawasaki, T.; Brahmandam, M.; Kirkner, G.J.; Laird, P.W.; Loda, M.; Fuchs, C.S. Correlation of pathologic features with CpG island methylator phenotype (CIMP) by quantitative DNA methylation analysis in colorectal carcinoma. Am. J. Surg. Pathol. 2006, 30, 1175-1183.
    • (2006) Am. J. Surg. Pathol. , vol.30 , pp. 1175-1183
    • Ogino, S.1    Odze, R.D.2    Kawasaki, T.3    Brahmandam, M.4    Kirkner, G.J.5    Laird, P.W.6    Loda, M.7    Fuchs, C.S.8
  • 71
    • 82555191051 scopus 로고    scopus 로고
    • Cancer immunology-Analysis of host and tumor factors for personalized medicine
    • Ogino, S.; Galon, J.; Fuchs, C.S.; Dranoff, G. Cancer immunology-Analysis of host and tumor factors for personalized medicine. Nat. Rev. Clin. Oncol. 2011, 8, 711-719.
    • (2011) Nat. Rev. Clin. Oncol. , vol.8 , pp. 711-719
    • Ogino, S.1    Galon, J.2    Fuchs, C.S.3    Dranoff, G.4
  • 74
    • 84858276725 scopus 로고    scopus 로고
    • Epigenetics of colorectal cancer
    • Migheli, F.; Migliore, L. Epigenetics of colorectal cancer. Clin. Genet. 2012, 81, 312-318.
    • (2012) Clin. Genet. , vol.81 , pp. 312-318
    • Migheli, F.1    Migliore, L.2
  • 78
    • 0842278570 scopus 로고    scopus 로고
    • Epigenetic changes in colorectal cancer
    • Kondo, Y.; Issa, J.P. Epigenetic changes in colorectal cancer. Cancer Metastasis Rev. 2004, 23, 29-39.
    • (2004) Cancer Metastasis Rev. , vol.23 , pp. 29-39
    • Kondo, Y.1    Issa, J.P.2
  • 79
    • 0026708177 scopus 로고
    • Targeted mutation of the DNA methyltransferase gene results in embryonic lethality
    • Li, E.; Bestor, T.H.; Jaenisch, R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 1992, 69, 915-926.
    • (1992) Cell , vol.69 , pp. 915-926
    • Li, E.1    Bestor, T.H.2    Jaenisch, R.3
  • 80
    • 0027348191 scopus 로고
    • X chromosome inactivation and DNA methylation
    • Singer-Sam, J.; Riggs, A.D. X chromosome inactivation and DNA methylation. EXS 1993, 64, 358-384.
    • (1993) EXS , vol.64 , pp. 358-384
    • Singer-Sam, J.1    Riggs, A.D.2
  • 81
    • 0027378582 scopus 로고
    • Role for DNA methylation in genomic imprinting
    • Li, E.; Beard, C.; Jaenisch, R. Role for DNA methylation in genomic imprinting. Nature 1993, 366, 362-365.
    • (1993) Nature , vol.366 , pp. 362-365
    • Li, E.1    Beard, C.2    Jaenisch, R.3
  • 82
    • 0036145156 scopus 로고    scopus 로고
    • Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours
    • Esteller, M.; Herman, J.G. Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours. J. Pathol. 2002, 196, 1-7.
    • (2002) J. Pathol. , vol.196 , pp. 1-7
    • Esteller, M.1    Herman, J.G.2
  • 83
    • 84876495060 scopus 로고    scopus 로고
    • CpG Island Methylation, Microsatellite Instability, and BRAF Mutations and Their Clinical Application in the Treatment of Colon Cancer
    • Wu, C.; Bekaii-Saab, T. CpG Island Methylation, Microsatellite Instability, and BRAF Mutations and Their Clinical Application in the Treatment of Colon Cancer. Chemother. Res. Pract. 2012, 2012, 359041.
    • (2012) Chemother. Res. Pract. , vol.2012 , pp. 359041
    • Wu, C.1    Bekaii-Saab, T.2
  • 84
    • 33644825262 scopus 로고    scopus 로고
    • Global DNA demethylation in gastrointestinal cancer is age dependent and precedes genomic damage
    • Suzuki, K.; Suzuki, I.; Leodolter, A.; Alonso, S.; Horiuchi, S.; Yamashita, K.; Perucho, M. Global DNA demethylation in gastrointestinal cancer is age dependent and precedes genomic damage. Cancer Cell 2006, 9, 199-207.
    • (2006) Cancer Cell , vol.9 , pp. 199-207
    • Suzuki, K.1    Suzuki, I.2    Leodolter, A.3    Alonso, S.4    Horiuchi, S.5    Yamashita, K.6    Perucho, M.7
  • 86
    • 0030983076 scopus 로고    scopus 로고
    • DNA methylation and genetic instability in colorectal cancer cells
    • Lengauer, C.; Kinzler, K.W.; Vogelstein, B. DNA methylation and genetic instability in colorectal cancer cells. Proc. Natl. Acad. Sci. USA 1997, 94, 2545-2550.
    • (1997) Proc. Natl. Acad. Sci. USA , vol.94 , pp. 2545-2550
    • Lengauer, C.1    Kinzler, K.W.2    Vogelstein, B.3
  • 87
    • 79956304468 scopus 로고    scopus 로고
    • Rapid and transient recruitment of DNMT1 to DNA double-strand breaks is mediated by its interaction with multiple components of the DNA damage response machinery
    • Ha, K.; Lee, G.E.; Palii, S.S.; Brown, K.D.; Takeda, Y.; Liu, K.; Bhalla, K.N.; Robertson, K.D. Rapid and transient recruitment of DNMT1 to DNA double-strand breaks is mediated by its interaction with multiple components of the DNA damage response machinery. Hum. Mol. Genet. 2011, 20, 126-140.
    • (2011) Hum. Mol. Genet. , vol.20 , pp. 126-140
    • Ha, K.1    Lee, G.E.2    Palii, S.S.3    Brown, K.D.4    Takeda, Y.5    Liu, K.6    Bhalla, K.N.7    Robertson, K.D.8
  • 88
    • 59149084538 scopus 로고    scopus 로고
    • The human colon cancer methylome shows similar hypo-and hypermethylation at conserved tissue-specific CpG island shores
    • Irizarry, R.A.; Ladd-Acosta, C.; Wen, B.; Wu, Z.; Montano, C.; Onyango, P.; Cui, H.; Gabo, K.; Rongione, M.; Webster, M.; et al. The human colon cancer methylome shows similar hypo-and hypermethylation at conserved tissue-specific CpG island shores. Nat. Genet. 2009, 41, 178-186.
    • (2009) Nat. Genet. , vol.41 , pp. 178-186
    • Irizarry, R.A.1    Ladd-Acosta, C.2    Wen, B.3    Wu, Z.4    Montano, C.5    Onyango, P.6    Cui, H.7    Gabo, K.8    Rongione, M.9    Webster, M.10
  • 92
    • 34249789850 scopus 로고    scopus 로고
    • 18q loss of heterozygosity in microsatellite stable colorectal cancer is correlated with CpG island methylator phenotype-negative (CIMP-0) and inversely with CIMP-low and CIMP-high
    • Ogino, S.; Kawasaki, T.; Kirkner, G.J.; Ohnishi, M.; Fuchs, C.S. 18q loss of heterozygosity in microsatellite stable colorectal cancer is correlated with CpG island methylator phenotype-negative (CIMP-0) and inversely with CIMP-low and CIMP-high. BMC Cancer 2007, 7, 72.
    • (2007) BMC Cancer , vol.7 , pp. 72
    • Ogino, S.1    Kawasaki, T.2    Kirkner, G.J.3    Ohnishi, M.4    Fuchs, C.S.5
  • 93
    • 43049130760 scopus 로고    scopus 로고
    • LINE-1 hypomethylation is inversely associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer
    • Ogino, S.; Kawasaki, T.; Nosho, K.; Ohnishi, M.; Suemoto, Y.; Kirkner, G.J.; Fuchs, C.S. LINE-1 hypomethylation is inversely associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer. Int. J. Cancer 2008, 122, 2767-2773.
    • (2008) Int. J. Cancer , vol.122 , pp. 2767-2773
    • Ogino, S.1    Kawasaki, T.2    Nosho, K.3    Ohnishi, M.4    Suemoto, Y.5    Kirkner, G.J.6    Fuchs, C.S.7
  • 96
    • 34548746357 scopus 로고    scopus 로고
    • Progressive up-regulation of genes encoding DNA methyltransferases in the colorectal adenoma-carcinoma sequence
    • Schmidt, W.M.; Sedivy, R.; Forstner, B.; Steger, G.G.; Zochbauer-Muller, S.; Mader, R.M. Progressive up-regulation of genes encoding DNA methyltransferases in the colorectal adenoma-carcinoma sequence. Mol. Carcinog. 2007, 46, 766-772.
    • (2007) Mol. Carcinog. , vol.46 , pp. 766-772
    • Schmidt, W.M.1    Sedivy, R.2    Forstner, B.3    Steger, G.G.4    Zochbauer-Muller, S.5    Mader, R.M.6
  • 98
    • 0032890965 scopus 로고    scopus 로고
    • The DNA methylation paradox
    • Jones, P.A. The DNA methylation paradox. Trends Genet. 1999, 15, 34-37.
    • (1999) Trends Genet. , vol.15 , pp. 34-37
    • Jones, P.A.1
  • 99
    • 0034929515 scopus 로고    scopus 로고
    • DNA methylation: An alternative pathway to cancer
    • Wajed, S.A.; Laird, P.W.; DeMeester, T.R. DNA methylation: An alternative pathway to cancer. Ann. Surg. 2001, 234, 10-20.
    • (2001) Ann. Surg. , vol.234 , pp. 10-20
    • Wajed, S.A.1    Laird, P.W.2    DeMeester, T.R.3
  • 100
    • 57749097557 scopus 로고    scopus 로고
    • DNA methylation represses IFN-gamma-induced and signal transducer and activator of transcription 1-mediated IFN regulatory factor 8 activation in colon carcinoma cells
    • McGough, J.M.; Yang, D.; Huang, S.; Georgi, D.; Hewitt, S.M.; Rocken, C.; Tanzer, M.; Ebert, M.P.; Liu, K. DNA methylation represses IFN-gamma-induced and signal transducer and activator of transcription 1-mediated IFN regulatory factor 8 activation in colon carcinoma cells. Mol. Cancer Res. 2008, 6, 1841-1851.
    • (2008) Mol. Cancer Res. , vol.6 , pp. 1841-1851
    • McGough, J.M.1    Yang, D.2    Huang, S.3    Georgi, D.4    Hewitt, S.M.5    Rocken, C.6    Tanzer, M.7    Ebert, M.P.8    Liu, K.9
  • 101
    • 34248230089 scopus 로고    scopus 로고
    • Repression of IFN regulatory factor 8 by DNA methylation is a molecular determinant of apoptotic resistance and metastatic phenotype in metastatic tumor cells
    • Yang, D.; Thangaraju, M.; Greeneltch, K.; Browning, D.D.; Schoenlein, P.V.; Tamura, T.; Ozato, K.; Ganapathy, V.; Abrams, S.I.; Liu, K. Repression of IFN regulatory factor 8 by DNA methylation is a molecular determinant of apoptotic resistance and metastatic phenotype in metastatic tumor cells. Cancer Res. 2007, 67, 3301-3309.
    • (2007) Cancer Res. , vol.67 , pp. 3301-3309
    • Yang, D.1    Thangaraju, M.2    Greeneltch, K.3    Browning, D.D.4    Schoenlein, P.V.5    Tamura, T.6    Ozato, K.7    Ganapathy, V.8    Abrams, S.I.9    Liu, K.10
  • 102
    • 80054790080 scopus 로고    scopus 로고
    • DNA methylation: Superior or subordinate in the epigenetic hierarchy?
    • Jin, B.; Li, Y.; Robertson, K.D. DNA methylation: Superior or subordinate in the epigenetic hierarchy? Genes Cancer 2011, 2, 607-617.
    • (2011) Genes Cancer , vol.2 , pp. 607-617
    • Jin, B.1    Li, Y.2    Robertson, K.D.3
  • 103
    • 0142153892 scopus 로고    scopus 로고
    • Eukaryotic methyl-CpG-binding domain proteins and chromatin modification
    • Hung, M.S.; Shen, C.K. Eukaryotic methyl-CpG-binding domain proteins and chromatin modification. Eukaryot. Cell 2003, 2, 841-846.
    • (2003) Eukaryot. Cell , vol.2 , pp. 841-846
    • Hung, M.S.1    Shen, C.K.2
  • 104
    • 80054790280 scopus 로고    scopus 로고
    • The Roles of the Methyl-CpG Binding Proteins in Cancer
    • Parry, L.; Clarke, A.R. The Roles of the Methyl-CpG Binding Proteins in Cancer. Genes Cancer 2011, 2, 618-630.
    • (2011) Genes Cancer , vol.2 , pp. 618-630
    • Parry, L.1    Clarke, A.R.2
  • 105
    • 0034807280 scopus 로고    scopus 로고
    • Methylation and colorectal cancer
    • Jubb, A.M.; Bell, S.M.; Quirke, P. Methylation and colorectal cancer. J. Pathol. 2001, 195, 111-134.
    • (2001) J. Pathol. , vol.195 , pp. 111-134
    • Jubb, A.M.1    Bell, S.M.2    Quirke, P.3
  • 106
    • 78649953952 scopus 로고    scopus 로고
    • Epigenetic silencing of peroxisome proliferator-activated receptor gamma is a biomarker for colorectal cancer progression and adverse patients' outcome
    • Pancione, M.; Sabatino, L.; Fucci, A.; Carafa, V.; Nebbioso, A.; Forte, N.; Febbraro, A.; Parente, D.; Ambrosino, C.; Normanno, N.; et al. Epigenetic silencing of peroxisome proliferator-activated receptor gamma is a biomarker for colorectal cancer progression and adverse patients' outcome. PLoS One 2010, 5, e14229.
    • (2010) PLoS One , vol.5
    • Pancione, M.1    Sabatino, L.2    Fucci, A.3    Carafa, V.4    Nebbioso, A.5    Forte, N.6    Febbraro, A.7    Parente, D.8    Ambrosino, C.9    Normanno, N.10
  • 110
    • 0033599013 scopus 로고    scopus 로고
    • Somatic frameshift mutations in the MBD4 gene of sporadic colon cancers with mismatch repair deficiency
    • Bader, S.; Walker, M.; Hendrich, B.; Bird, A.; Bird, C.; Hooper, M.; Wyllie, A. Somatic frameshift mutations in the MBD4 gene of sporadic colon cancers with mismatch repair deficiency. Oncogene 1999, 18, 8044-8047.
    • (1999) Oncogene , vol.18 , pp. 8044-8047
    • Bader, S.1    Walker, M.2    Hendrich, B.3    Bird, A.4    Bird, C.5    Hooper, M.6    Wyllie, A.7
  • 111
    • 0034543135 scopus 로고    scopus 로고
    • Most microsatellite unstable sporadic colorectal carcinomas carry MBD4 mutations
    • Bader, S.; Walker, M.; Harrison, D. Most microsatellite unstable sporadic colorectal carcinomas carry MBD4 mutations. Br. J. Cancer 2000, 83, 1646-1649.
    • (2000) Br. J. Cancer , vol.83 , pp. 1646-1649
    • Bader, S.1    Walker, M.2    Harrison, D.3
  • 112
    • 33847233256 scopus 로고    scopus 로고
    • A human cancer-associated truncation of MBD4 causes dominant negative impairment of DNA repair in colon cancer cells
    • Bader, S.A.; Walker, M.; Harrison, D.J. A human cancer-associated truncation of MBD4 causes dominant negative impairment of DNA repair in colon cancer cells. Br. J. Cancer 2007, 96, 660-666.
    • (2007) Br. J. Cancer , vol.96 , pp. 660-666
    • Bader, S.A.1    Walker, M.2    Harrison, D.J.3
  • 114
    • 70349742486 scopus 로고    scopus 로고
    • DNMT1 and DNMT3B modulate distinct polycomb-mediated histone modifications in colon cancer
    • Jin, B.; Yao, B.; Li, J.L.; Fields, C.R.; Delmas, A.L.; Liu, C.; Robertson, K.D. DNMT1 and DNMT3B modulate distinct polycomb-mediated histone modifications in colon cancer. Cancer Res. 2009, 69, 7412-7421.
    • (2009) Cancer Res. , vol.69 , pp. 7412-7421
    • Jin, B.1    Yao, B.2    Li, J.L.3    Fields, C.R.4    Delmas, A.L.5    Liu, C.6    Robertson, K.D.7
  • 116
    • 68049137611 scopus 로고    scopus 로고
    • Polycomb CBX7 promotes initiation of heritable repression of genes frequently silenced with cancer-specific DNA hypermethylation
    • Mohammad, H.P.; Cai, Y.; McGarvey, K.M.; Easwaran, H.; van Neste, L.; Ohm, J.E.; O'Hagan, H.M.; Baylin, S.B. Polycomb CBX7 promotes initiation of heritable repression of genes frequently silenced with cancer-specific DNA hypermethylation. Cancer Res. 2009, 69, 6322-6330.
    • (2009) Cancer Res. , vol.69 , pp. 6322-6330
    • Mohammad, H.P.1    Cai, Y.2    McGarvey, K.M.3    Easwaran, H.4    van Neste, L.5    Ohm, J.E.6    O'Hagan, H.M.7    Baylin, S.B.8
  • 117
    • 67650088336 scopus 로고    scopus 로고
    • Clinicopathological implications of EpCAM expression in adenocarcinoma of the lung
    • Kim, Y.; Kim, H.S.; Cui, Z.Y.; Lee, H.S.; Ahn, J.S.; Park, C.K.; Park, K.; Ahn, M.J. Clinicopathological implications of EpCAM expression in adenocarcinoma of the lung. Anticancer Res. 2009, 29, 1817-1822.
    • (2009) Anticancer Res. , vol.29 , pp. 1817-1822
    • Kim, Y.1    Kim, H.S.2    Cui, Z.Y.3    Lee, H.S.4    Ahn, J.S.5    Park, C.K.6    Park, K.7    Ahn, M.J.8
  • 118
    • 33846569960 scopus 로고    scopus 로고
    • A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing
    • Ohm, J.E.; McGarvey, K.M.; Yu, X.; Cheng, L.; Schuebel, K.E.; Cope, L.; Mohammad, H.P.; Chen, W.; Daniel, V.C.; Yu, W.; et al. A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat. Genet. 2007, 39, 237-242.
    • (2007) Nat. Genet. , vol.39 , pp. 237-242
    • Ohm, J.E.1    McGarvey, K.M.2    Yu, X.3    Cheng, L.4    Schuebel, K.E.5    Cope, L.6    Mohammad, H.P.7    Chen, W.8    Daniel, V.C.9    Yu, W.10
  • 120
    • 0033946039 scopus 로고    scopus 로고
    • DNA mismatch repair genes and colorectal cancer
    • Wheeler, J.M.; Bodmer, W.F.; Mortensen, N.J. DNA mismatch repair genes and colorectal cancer. Gut 2000, 47, 148-153.
    • (2000) Gut , vol.47 , pp. 148-153
    • Wheeler, J.M.1    Bodmer, W.F.2    Mortensen, N.J.3
  • 125
    • 77952449085 scopus 로고    scopus 로고
    • Comprehensive profiling of DNA methylation in colorectal cancer reveals subgroups with distinct clinicopathological and molecular features
    • Ang, P.W.; Loh, M.; Liem, N.; Lim, P.L.; Grieu, F.; Vaithilingam, A.; Platell, C.; Yong, W.P.; Iacopetta, B.; Soong, R. Comprehensive profiling of DNA methylation in colorectal cancer reveals subgroups with distinct clinicopathological and molecular features. BMC Cancer 2010, 10, 227.
    • (2010) BMC Cancer , vol.10 , pp. 227
    • Ang, P.W.1    Loh, M.2    Liem, N.3    Lim, P.L.4    Grieu, F.5    Vaithilingam, A.6    Platell, C.7    Yong, W.P.8    Iacopetta, B.9    Soong, R.10
  • 126
    • 0142087630 scopus 로고    scopus 로고
    • Adverse prognostic effect of methylation in colorectal cancer is reversed by microsatellite instability
    • Ward, R.L.; Cheong, K.; Ku, S.L.; Meagher, A.; O'Connor, T.; Hawkins, N.J. Adverse prognostic effect of methylation in colorectal cancer is reversed by microsatellite instability. J. Clin. Oncol. 2003, 21, 3729-3736.
    • (2003) J. Clin. Oncol. , vol.21 , pp. 3729-3736
    • Ward, R.L.1    Cheong, K.2    Ku, S.L.3    Meagher, A.4    O'Connor, T.5    Hawkins, N.J.6
  • 127
    • 0041524111 scopus 로고    scopus 로고
    • CpG island methylator phenotype is an independent predictor of survival benefit from 5-fluorouracil in stage III colorectal cancer
    • Van Rijnsoever, M.; Elsaleh, H.; Joseph, D.; McCaul, K.; Iacopetta, B. CpG island methylator phenotype is an independent predictor of survival benefit from 5-fluorouracil in stage III colorectal cancer. Clin. Cancer Res. 2003, 9, 2898-2903.
    • (2003) Clin. Cancer Res. , vol.9 , pp. 2898-2903
    • van Rijnsoever, M.1    Elsaleh, H.2    Joseph, D.3    McCaul, K.4    Iacopetta, B.5
  • 129
    • 38149135181 scopus 로고    scopus 로고
    • Clinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation
    • Lee, S.; Cho, N.Y.; Choi, M.; Yoo, E.J.; Kim, J.H.; Kang, G.H. Clinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation. Pathol. Int. 2008, 58, 104-113.
    • (2008) Pathol. Int. , vol.58 , pp. 104-113
    • Lee, S.1    Cho, N.Y.2    Choi, M.3    Yoo, E.J.4    Kim, J.H.5    Kang, G.H.6
  • 130
    • 58249089525 scopus 로고    scopus 로고
    • CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer
    • Ogino, S.; Nosho, K.; Kirkner, G.J.; Kawasaki, T.; Meyerhardt, J.A.; Loda, M.; Giovannucci, E.L.; Fuchs, C.S. CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer. Gut 2009, 58, 90-96.
    • (2009) Gut , vol.58 , pp. 90-96
    • Ogino, S.1    Nosho, K.2    Kirkner, G.J.3    Kawasaki, T.4    Meyerhardt, J.A.5    Loda, M.6    Giovannucci, E.L.7    Fuchs, C.S.8
  • 133
    • 0031004175 scopus 로고    scopus 로고
    • Genetic instability in colorectal cancers
    • Lengauer, C.; Kinzler, K.W.; Vogelstein, B. Genetic instability in colorectal cancers. Nature 1997, 386, 623-627.
    • (1997) Nature , vol.386 , pp. 623-627
    • Lengauer, C.1    Kinzler, K.W.2    Vogelstein, B.3
  • 134
    • 0028830692 scopus 로고
    • Genomic imprinting proposed as a surveillance mechanism for chromosome loss
    • Thomas, J.H. Genomic imprinting proposed as a surveillance mechanism for chromosome loss. Proc. Natl. Acad. Sci. USA 1995, 92, 480-482.
    • (1995) Proc. Natl. Acad. Sci. USA , vol.92 , pp. 480-482
    • Thomas, J.H.1
  • 135
    • 0031018674 scopus 로고    scopus 로고
    • Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype
    • Rampino, N.; Yamamoto, H.; Ionov, Y.; Li, Y.; Sawai, H.; Reed, J.C.; Perucho, M. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 1997, 275, 967-969.
    • (1997) Science , vol.275 , pp. 967-969
    • Rampino, N.1    Yamamoto, H.2    Ionov, Y.3    Li, Y.4    Sawai, H.5    Reed, J.C.6    Perucho, M.7
  • 138
    • 33749069927 scopus 로고    scopus 로고
    • CpG island methylator phenotype-low (CIMP-low) in colorectal cancer: Possible associations with male sex and KRAS mutations
    • Ogino, S.; Kawasaki, T.; Kirkner, G.J.; Loda, M.; Fuchs, C.S. CpG island methylator phenotype-low (CIMP-low) in colorectal cancer: Possible associations with male sex and KRAS mutations. J. Mol. Diagn. 2006, 8, 582-588.
    • (2006) J. Mol. Diagn. , vol.8 , pp. 582-588
    • Ogino, S.1    Kawasaki, T.2    Kirkner, G.J.3    Loda, M.4    Fuchs, C.S.5
  • 139
    • 0035328527 scopus 로고    scopus 로고
    • Accelerated age-related CpG island methylation in ulcerative colitis
    • Issa, J.P.; Ahuja, N.; Toyota, M.; Bronner, M.P.; Brentnall, T.A. Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res. 2001, 61, 3573-3577.
    • (2001) Cancer Res. , vol.61 , pp. 3573-3577
    • Issa, J.P.1    Ahuja, N.2    Toyota, M.3    Bronner, M.P.4    Brentnall, T.A.5
  • 140
    • 80755173982 scopus 로고    scopus 로고
    • Relative role of methylator and tumor suppressor pathways in ulcerative colitis-associated colon cancer
    • Sanchez, J.A.; Dejulius, K.L.; Bronner, M.; Church, J.M.; Kalady, M.F. Relative role of methylator and tumor suppressor pathways in ulcerative colitis-associated colon cancer. Inflamm. Bowel Dis. 2011, 17, 1966-1970.
    • (2011) Inflamm. Bowel Dis. , vol.17 , pp. 1966-1970
    • Sanchez, J.A.1    Dejulius, K.L.2    Bronner, M.3    Church, J.M.4    Kalady, M.F.5
  • 142
    • 34247273521 scopus 로고    scopus 로고
    • Rare CpG island methylator phenotype in ulcerative colitis-associated neoplasias
    • Konishi, K.; Shen, L.; Wang, S.; Meltzer, S.J.; Harpaz, N.; Issa, J.P. Rare CpG island methylator phenotype in ulcerative colitis-associated neoplasias. Gastroenterology 2007, 132, 1254-1260.
    • (2007) Gastroenterology , vol.132 , pp. 1254-1260
    • Konishi, K.1    Shen, L.2    Wang, S.3    Meltzer, S.J.4    Harpaz, N.5    Issa, J.P.6
  • 143
    • 0034282793 scopus 로고    scopus 로고
    • Microsatellite instability in inflammatory bowel disease-associated neoplastic lesions is associated with hypermethylation and diminished expression of the DNA mismatch repair gene, hMLH1
    • Fleisher, A.S.; Esteller, M.; Harpaz, N.; Leytin, A.; Rashid, A.; Xu, Y.; Liang, J.; Stine, O.C.; Yin, J.; Zou, T.T.; et al. Microsatellite instability in inflammatory bowel disease-associated neoplastic lesions is associated with hypermethylation and diminished expression of the DNA mismatch repair gene, hMLH1. Cancer Res. 2000, 60, 4864-4868.
    • (2000) Cancer Res. , vol.60 , pp. 4864-4868
    • Fleisher, A.S.1    Esteller, M.2    Harpaz, N.3    Leytin, A.4    Rashid, A.5    Xu, Y.6    Liang, J.7    Stine, O.C.8    Yin, J.9    Zou, T.T.10
  • 148
    • 79955397102 scopus 로고    scopus 로고
    • DNA methylation predicts recurrence from resected stage III proximal colon cancer
    • Ahn, J.B.; Chung, W.B.; Maeda, O.; Shin, S.J.; Kim, H.S.; Chung, H.C.; Kim, N.K.; Issa, J.P. DNA methylation predicts recurrence from resected stage III proximal colon cancer. Cancer 2011, 117, 1847-1854.
    • (2011) Cancer , vol.117 , pp. 1847-1854
    • Ahn, J.B.1    Chung, W.B.2    Maeda, O.3    Shin, S.J.4    Kim, H.S.5    Chung, H.C.6    Kim, N.K.7    Issa, J.P.8
  • 149
    • 84868208197 scopus 로고    scopus 로고
    • Clinical outcomes of patients with microsatellite-unstable colorectal carcinomas depend on L1 methylation level
    • Rhee, Y.Y.; Kim, M.J.; Bae, J.M.; Koh, J.M.; Cho, N.Y.; Juhnn, Y.S.; Kim, D.; Kang, G.H. Clinical outcomes of patients with microsatellite-unstable colorectal carcinomas depend on L1 methylation level. Ann. Surg. Oncol. 2012, 19, 3441-3448.
    • (2012) Ann. Surg. Oncol. , vol.19 , pp. 3441-3448
    • Rhee, Y.Y.1    Kim, M.J.2    Bae, J.M.3    Koh, J.M.4    Cho, N.Y.5    Juhnn, Y.S.6    Kim, D.7    Kang, G.H.8
  • 151
    • 84859893371 scopus 로고    scopus 로고
    • Histone methylation: A dynamic mark in health, disease and inheritance
    • Greer, E.L.; Shi, Y. Histone methylation: A dynamic mark in health, disease and inheritance. Nat. Rev. Genet. 2012, 13, 343-357.
    • (2012) Nat. Rev. Genet. , vol.13 , pp. 343-357
    • Greer, E.L.1    Shi, Y.2
  • 153
    • 84861937510 scopus 로고    scopus 로고
    • Silencing of Wnt5a during colon cancer metastasis involves histone modifications
    • Li, Q.; Chen, H. Silencing of Wnt5a during colon cancer metastasis involves histone modifications. Epigenetics 2012, 7, 551-558.
    • (2012) Epigenetics , vol.7 , pp. 551-558
    • Li, Q.1    Chen, H.2
  • 154
    • 84876207842 scopus 로고    scopus 로고
    • Transcriptional regulation by histone modifications: Towards a theory of chromatin re-organization during stem cell differentiation
    • Binder, H.; Steiner, L.; Przybilla, J.; Rohlf, T.; Prohaska, S.; Galle, J. Transcriptional regulation by histone modifications: Towards a theory of chromatin re-organization during stem cell differentiation. Phys. Biol. 2013, 10, 026006.
    • (2013) Phys. Biol. , vol.10 , pp. 026006
    • Binder, H.1    Steiner, L.2    Przybilla, J.3    Rohlf, T.4    Prohaska, S.5    Galle, J.6
  • 155
    • 79952534189 scopus 로고    scopus 로고
    • Regulation of chromatin by histone modifications
    • Bannister, A.J.; Kouzarides, T. Regulation of chromatin by histone modifications. Cell Res. 2011, 21, 381-395.
    • (2011) Cell Res. , vol.21 , pp. 381-395
    • Bannister, A.J.1    Kouzarides, T.2
  • 156
    • 0034051227 scopus 로고    scopus 로고
    • Acetylation of histones and transcription-related factors
    • Sterner, D.E.; Berger, S.L. Acetylation of histones and transcription-related factors. Microbiol. Mol. Biol. Rev. 2000, 64, 435-459.
    • (2000) Microbiol. Mol. Biol. Rev. , vol.64 , pp. 435-459
    • Sterner, D.E.1    Berger, S.L.2
  • 157
    • 18844413266 scopus 로고    scopus 로고
    • Acetylation in histone H3 globular domain regulates gene expression in yeast
    • Xu, F.; Zhang, K.; Grunstein, M. Acetylation in histone H3 globular domain regulates gene expression in yeast. Cell 2005, 121, 375-385.
    • (2005) Cell , vol.121 , pp. 375-385
    • Xu, F.1    Zhang, K.2    Grunstein, M.3
  • 158
    • 33846796258 scopus 로고    scopus 로고
    • Rtt109 acetylates histone H3 lysine 56 and functions in DNA replication
    • Han, J.; Zhou, H.; Horazdovsky, B.; Zhang, K.; Xu, R.M.; Zhang, Z. Rtt109 acetylates histone H3 lysine 56 and functions in DNA replication. Science 2007, 315, 653-655.
    • (2007) Science , vol.315 , pp. 653-655
    • Han, J.1    Zhou, H.2    Horazdovsky, B.3    Zhang, K.4    Xu, R.M.5    Zhang, Z.6
  • 159
    • 33846818840 scopus 로고    scopus 로고
    • Yeast Rtt109 promotes genome stability by acetylating histone H3 on lysine 56
    • Driscoll, R.; Hudson, A.; Jackson, S.P. Yeast Rtt109 promotes genome stability by acetylating histone H3 on lysine 56. Science 2007, 315, 649-652.
    • (2007) Science , vol.315 , pp. 649-652
    • Driscoll, R.1    Hudson, A.2    Jackson, S.P.3
  • 160
    • 33846023720 scopus 로고    scopus 로고
    • Rtt109 is required for proper H3K56 acetylation: A chromatin mark associated with the elongating RNA polymerase II
    • Schneider, J.; Bajwa, P.; Johnson, F.C.; Bhaumik, S.R.; Shilatifard, A. Rtt109 is required for proper H3K56 acetylation: A chromatin mark associated with the elongating RNA polymerase II. J. Biol. Chem. 2006, 281, 37270-37274.
    • (2006) J. Biol. Chem. , vol.281 , pp. 37270-37274
    • Schneider, J.1    Bajwa, P.2    Johnson, F.C.3    Bhaumik, S.R.4    Shilatifard, A.5
  • 162
    • 41549159879 scopus 로고    scopus 로고
    • Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: Specific role of class I histone deacetylases in vitro and in vivo
    • Weichert, W.; Roske, A.; Niesporek, S.; Noske, A.; Buckendahl, A.C.; Dietel, M.; Gekeler, V.; Boehm, M.; Beckers, T.; Denkert, C. Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: Specific role of class I histone deacetylases in vitro and in vivo. Clin. Cancer Res. 2008, 14, 1669-1677.
    • (2008) Clin. Cancer Res. , vol.14 , pp. 1669-1677
    • Weichert, W.1    Roske, A.2    Niesporek, S.3    Noske, A.4    Buckendahl, A.C.5    Dietel, M.6    Gekeler, V.7    Boehm, M.8    Beckers, T.9    Denkert, C.10
  • 165
    • 67650691722 scopus 로고    scopus 로고
    • SIRT1 histone deacetylase expression is associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer
    • Nosho, K.; Shima, K.; Irahara, N.; Kure, S.; Firestein, R.; Baba, Y.; Toyoda, S.; Chen, L.; Hazra, A.; Giovannucci, E.L.; et al. SIRT1 histone deacetylase expression is associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer. Mod. Pathol. 2009, 22, 922-932.
    • (2009) Mod. Pathol. , vol.22 , pp. 922-932
    • Nosho, K.1    Shima, K.2    Irahara, N.3    Kure, S.4    Firestein, R.5    Baba, Y.6    Toyoda, S.7    Chen, L.8    Hazra, A.9    Giovannucci, E.L.10
  • 166
    • 0034610814 scopus 로고    scopus 로고
    • The language of covalent histone modifications
    • Strahl, B.D.; Allis, C.D. The language of covalent histone modifications. Nature 2000, 403, 41-45.
    • (2000) Nature , vol.403 , pp. 41-45
    • Strahl, B.D.1    Allis, C.D.2
  • 167
    • 33846019277 scopus 로고    scopus 로고
    • Methylation of lysine 4 on histone H3: Intricacy of writing and reading a single epigenetic mark
    • Ruthenburg, A.J.; Allis, C.D.; Wysocka, J. Methylation of lysine 4 on histone H3: Intricacy of writing and reading a single epigenetic mark. Mol. Cell 2007, 25, 15-30.
    • (2007) Mol. Cell , vol.25 , pp. 15-30
    • Ruthenburg, A.J.1    Allis, C.D.2    Wysocka, J.3
  • 168
    • 33947513027 scopus 로고    scopus 로고
    • Regulation of histone methylation by demethylimination and demethylation
    • Klose, R.J.; Zhang, Y. Regulation of histone methylation by demethylimination and demethylation. Nat. Rev. Mol. Cell Biol. 2007, 8, 307-318.
    • (2007) Nat. Rev. Mol. Cell Biol. , vol.8 , pp. 307-318
    • Klose, R.J.1    Zhang, Y.2
  • 170
    • 79959960773 scopus 로고    scopus 로고
    • The diverse functions of Dot1 and H3K79 methylation
    • Nguyen, A.T.; Zhang, Y. The diverse functions of Dot1 and H3K79 methylation. Genes Dev. 2011, 25, 1345-1358.
    • (2011) Genes Dev. , vol.25 , pp. 1345-1358
    • Nguyen, A.T.1    Zhang, Y.2
  • 171
    • 33845451555 scopus 로고    scopus 로고
    • Profile of histone lysine methylation across transcribed mammalian chromatin
    • Vakoc, C.R.; Sachdeva, M.M.; Wang, H.; Blobel, G.A. Profile of histone lysine methylation across transcribed mammalian chromatin. Mol. Cell Biol. 2006, 26, 9185-9195.
    • (2006) Mol. Cell Biol. , vol.26 , pp. 9185-9195
    • Vakoc, C.R.1    Sachdeva, M.M.2    Wang, H.3    Blobel, G.A.4
  • 174
    • 33847076849 scopus 로고    scopus 로고
    • Chromatin modifications and their function
    • Kouzarides, T. Chromatin modifications and their function. Cell 2007, 128, 693-705.
    • (2007) Cell , vol.128 , pp. 693-705
    • Kouzarides, T.1
  • 176
    • 55949136562 scopus 로고    scopus 로고
    • Roles of the EZH2 histone methyltransferase in cancer epigenetics
    • Simon, J.A.; Lange, C.A. Roles of the EZH2 histone methyltransferase in cancer epigenetics. Mutat. Res. 2008, 647, 21-29.
    • (2008) Mutat. Res. , vol.647 , pp. 21-29
    • Simon, J.A.1    Lange, C.A.2
  • 177
    • 70350500219 scopus 로고    scopus 로고
    • Polycomb group proteins: Navigators of lineage pathways led astray in cancer
    • Bracken, A.P.; Helin, K. Polycomb group proteins: Navigators of lineage pathways led astray in cancer. Nat. Rev. Cancer 2009, 9, 773-784.
    • (2009) Nat. Rev. Cancer , vol.9 , pp. 773-784
    • Bracken, A.P.1    Helin, K.2
  • 178
    • 58149214373 scopus 로고    scopus 로고
    • Regulation of pancreatic tumor cell proliferation and chemoresistance by the histone methyltransferase enhancer of zeste homologue 2
    • Ougolkov, A.V.; Bilim, V.N.; Billadeau, D.D. Regulation of pancreatic tumor cell proliferation and chemoresistance by the histone methyltransferase enhancer of zeste homologue 2. Clin. Cancer Res. 2008, 14, 6790-6796.
    • (2008) Clin. Cancer Res. , vol.14 , pp. 6790-6796
    • Ougolkov, A.V.1    Bilim, V.N.2    Billadeau, D.D.3
  • 179
    • 60149096212 scopus 로고    scopus 로고
    • Downregulation of EZH2 decreases growth of estrogen receptor-negative invasive breast carcinoma and requires BRCA1
    • Gonzalez, M.E.; Li, X.; Toy, K.; DuPrie, M.; Ventura, A.C.; Banerjee, M.; Ljungman, M.; Merajver, S.D.; Kleer, C.G. Downregulation of EZH2 decreases growth of estrogen receptor-negative invasive breast carcinoma and requires BRCA1. Oncogene 2009, 28, 843-853.
    • (2009) Oncogene , vol.28 , pp. 843-853
    • Gonzalez, M.E.1    Li, X.2    Toy, K.3    DuPrie, M.4    Ventura, A.C.5    Banerjee, M.6    Ljungman, M.7    Merajver, S.D.8    Kleer, C.G.9
  • 182
    • 35348914451 scopus 로고    scopus 로고
    • Association of the SUV39H1 histone methyltransferase with the DNA methyltransferase 1 at mRNA expression level in primary colorectal cancer
    • Kang, M.Y.; Lee, B.B.; Kim, Y.H.; Chang, D.K.; Kyu Park, S.; Chun, H.K.; Song, S.Y.; Park, J.; Kim, D.H. Association of the SUV39H1 histone methyltransferase with the DNA methyltransferase 1 at mRNA expression level in primary colorectal cancer. Int. J. Cancer 2007, 121, 2192-2197.
    • (2007) Int. J. Cancer , vol.121 , pp. 2192-2197
    • Kang, M.Y.1    Lee, B.B.2    Kim, Y.H.3    Chang, D.K.4    Kyu Park, S.5    Chun, H.K.6    Song, S.Y.7    Park, J.8    Kim, D.H.9
  • 187
    • 61349141809 scopus 로고    scopus 로고
    • Clinicopathological significance of microRNA-31,-143 and-145 expression in colorectal cancer
    • Wang, C.J.; Zhou, Z.G.; Wang, L.; Yang, L.; Zhou, B.; Gu, J.; Chen, H.Y.; Sun, X.F. Clinicopathological significance of microRNA-31,-143 and-145 expression in colorectal cancer. Dis. Markers 2009, 26, 27-34.
    • (2009) Dis. Markers , vol.26 , pp. 27-34
    • Wang, C.J.1    Zhou, Z.G.2    Wang, L.3    Yang, L.4    Zhou, B.5    Gu, J.6    Chen, H.Y.7    Sun, X.F.8
  • 188
    • 79959208404 scopus 로고    scopus 로고
    • Identification and functional analysis of epigenetically silenced microRNAs in colorectal cancer cells
    • Yan, H.; Choi, A.J.; Lee, B.H.; Ting, A.H. Identification and functional analysis of epigenetically silenced microRNAs in colorectal cancer cells. PLoS One 2011, 6, e20628.
    • (2011) PLoS One , vol.6
    • Yan, H.1    Choi, A.J.2    Lee, B.H.3    Ting, A.H.4
  • 192
  • 195
    • 77954368612 scopus 로고    scopus 로고
    • Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma
    • Earle, J.S.; Luthra, R.; Romans, A.; Abraham, R.; Ensor, J.; Yao, H.; Hamilton, S.R. Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma. J. Mol. Diagn. 2010, 12, 433-440.
    • (2010) J. Mol. Diagn. , vol.12 , pp. 433-440
    • Earle, J.S.1    Luthra, R.2    Romans, A.3    Abraham, R.4    Ensor, J.5    Yao, H.6    Hamilton, S.R.7
  • 196
    • 79954455860 scopus 로고    scopus 로고
    • Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas
    • Vogt, M.; Munding, J.; Gruner, M.; Liffers, S.T.; Verdoodt, B.; Hauk, J.; Steinstraesser, L.; Tannapfel, A.; Hermeking, H. Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas. Virchows Arch. 2011, 458, 313-322.
    • (2011) Virchows Arch. , vol.458 , pp. 313-322
    • Vogt, M.1    Munding, J.2    Gruner, M.3    Liffers, S.T.4    Verdoodt, B.5    Hauk, J.6    Steinstraesser, L.7    Tannapfel, A.8    Hermeking, H.9
  • 197
    • 81155158414 scopus 로고    scopus 로고
    • Dicer and miRNA in relation to clinicopathological variables in colorectal cancer patients
    • Stratmann, J.; Wang, C.J.; Gnosa, S.; Wallin, A.; Hinselwood, D.; Sun, X.F.; Zhang, H. Dicer and miRNA in relation to clinicopathological variables in colorectal cancer patients. BMC Cancer 2011, 11, 345.
    • (2011) BMC Cancer , vol.11 , pp. 345
    • Stratmann, J.1    Wang, C.J.2    Gnosa, S.3    Wallin, A.4    Hinselwood, D.5    Sun, X.F.6    Zhang, H.7
  • 199
    • 0037115392 scopus 로고    scopus 로고
    • Dependence of histone modifications and gene expression on DNA hypermethylation in cancer
    • Fahrner, J.A.; Eguchi, S.; Herman, J.G.; Baylin, S.B. Dependence of histone modifications and gene expression on DNA hypermethylation in cancer. Cancer Res. 2002, 62, 7213-7218.
    • (2002) Cancer Res. , vol.62 , pp. 7213-7218
    • Fahrner, J.A.1    Eguchi, S.2    Herman, J.G.3    Baylin, S.B.4
  • 200
    • 71049136170 scopus 로고    scopus 로고
    • MicroRNAs in colorectal cancer: Translation of molecular biology into clinical application
    • Slaby, O.; Svoboda, M.; Michalek, J.; Vyzula, R. MicroRNAs in colorectal cancer: Translation of molecular biology into clinical application. Mol. Cancer 2009, 8, 102.
    • (2009) Mol. Cancer , vol.8 , pp. 102
    • Slaby, O.1    Svoboda, M.2    Michalek, J.3    Vyzula, R.4
  • 201
    • 41649093940 scopus 로고    scopus 로고
    • The methylator phenotype in microsatellite stable colorectal cancers is characterized by a distinct gene expression profile
    • Ferracin, M.; Gafa, R.; Miotto, E.; Veronese, A.; Pultrone, C.; Sabbioni, S.; Lanza, G.; Negrini, M. The methylator phenotype in microsatellite stable colorectal cancers is characterized by a distinct gene expression profile. J. Pathol. 2008, 214, 594-602.
    • (2008) J. Pathol. , vol.214 , pp. 594-602
    • Ferracin, M.1    Gafa, R.2    Miotto, E.3    Veronese, A.4    Pultrone, C.5    Sabbioni, S.6    Lanza, G.7    Negrini, M.8
  • 202
    • 84868451906 scopus 로고    scopus 로고
    • SPARC and DNA methylation: Possible diagnostic and therapeutic implications in gastrointestinal cancers
    • Nagaraju, G.P.; El-Rayes, B.F. SPARC and DNA methylation: Possible diagnostic and therapeutic implications in gastrointestinal cancers. Cancer Lett. 2013, 328, 10-17.
    • (2013) Cancer Lett. , vol.328 , pp. 10-17
    • Nagaraju, G.P.1    El-Rayes, B.F.2
  • 203
    • 20444461133 scopus 로고    scopus 로고
    • Genome-wide expression analysis of therapy-resistant tumors reveals SPARC as a novel target for cancer therapy
    • Tai, I.T.; Dai, M.; Owen, D.A.; Chen, L.B. Genome-wide expression analysis of therapy-resistant tumors reveals SPARC as a novel target for cancer therapy. J. Clin. Invest. 2005, 115, 1492-1502.
    • (2005) J. Clin. Invest. , vol.115 , pp. 1492-1502
    • Tai, I.T.1    Dai, M.2    Owen, D.A.3    Chen, L.B.4
  • 204
    • 55949136282 scopus 로고    scopus 로고
    • SPARC in cancer biology: Its role in cancer progression and potential for therapy
    • Tai, I.T.; Tang, M.J. SPARC in cancer biology: Its role in cancer progression and potential for therapy. Drug Resist. Updat. 2008, 11, 231-246.
    • (2008) Drug Resist. Updat. , vol.11 , pp. 231-246
    • Tai, I.T.1    Tang, M.J.2
  • 205
    • 80054084433 scopus 로고    scopus 로고
    • Epigenetics and chemoresistance in colorectal cancer: An opportunity for treatment tailoring and novel therapeutic strategies
    • Crea, F.; Nobili, S.; Paolicchi, E.; Perrone, G.; Napoli, C.; Landini, I.; Danesi, R.; Mini, E. Epigenetics and chemoresistance in colorectal cancer: An opportunity for treatment tailoring and novel therapeutic strategies. Drug Resist. Updat. 2011, 14, 280-296.
    • (2011) Drug Resist. Updat. , vol.14 , pp. 280-296
    • Crea, F.1    Nobili, S.2    Paolicchi, E.3    Perrone, G.4    Napoli, C.5    Landini, I.6    Danesi, R.7    Mini, E.8
  • 206
    • 30644474460 scopus 로고    scopus 로고
    • Identification of a specific inhibitor of the histone methyltransferase SU(VAR)3-9
    • Greiner, D.; Bonaldi, T.; Eskeland, R.; Roemer, E.; Imhof, A. Identification of a specific inhibitor of the histone methyltransferase SU(VAR)3-9. Nat. Chem. Biol. 2005, 1, 143-145.
    • (2005) Nat. Chem. Biol. , vol.1 , pp. 143-145
    • Greiner, D.1    Bonaldi, T.2    Eskeland, R.3    Roemer, E.4    Imhof, A.5
  • 213
    • 84863497603 scopus 로고    scopus 로고
    • A dynamic multi-compartmental model of DNA methylation with demonstrable predictive value in hematological malignancies
    • McGovern, A.P.; Powell, B.E.; Chevassut, T.J. A dynamic multi-compartmental model of DNA methylation with demonstrable predictive value in hematological malignancies. J. Theor. Biol. 2012, 310, 14-20.
    • (2012) J. Theor. Biol. , vol.310 , pp. 14-20
    • McGovern, A.P.1    Powell, B.E.2    Chevassut, T.J.3
  • 214
    • 65249157050 scopus 로고    scopus 로고
    • Epigenetics, DNA methylation, and chromatin modifying drugs
    • Szyf, M. Epigenetics, DNA methylation, and chromatin modifying drugs. Annu. Rev. Pharmacol. Toxicol. 2009, 49, 243-263.
    • (2009) Annu. Rev. Pharmacol. Toxicol. , vol.49 , pp. 243-263
    • Szyf, M.1
  • 217
    • 66249127951 scopus 로고    scopus 로고
    • A new class of quinoline-based DNA hypomethylating agents reactivates tumor suppressor genes by blocking DNA methyltransferase 1 activity and inducing its degradation
    • Datta, J.; Ghoshal, K.; Denny, W.A.; Gamage, S.A.; Brooke, D.G.; Phiasivongsa, P.; Redkar, S.; Jacob, S.T. A new class of quinoline-based DNA hypomethylating agents reactivates tumor suppressor genes by blocking DNA methyltransferase 1 activity and inducing its degradation. Cancer Res. 2009, 69, 4277-4285.
    • (2009) Cancer Res. , vol.69 , pp. 4277-4285
    • Datta, J.1    Ghoshal, K.2    Denny, W.A.3    Gamage, S.A.4    Brooke, D.G.5    Phiasivongsa, P.6    Redkar, S.7    Jacob, S.T.8
  • 218
    • 31544441371 scopus 로고    scopus 로고
    • Inhibition of DNA methylation by caffeic acid and chlorogenic acid, two common catechol-containing coffee polyphenols
    • Lee, W.J.; Zhu, B.T. Inhibition of DNA methylation by caffeic acid and chlorogenic acid, two common catechol-containing coffee polyphenols. Carcinogenesis 2006, 27, 269-277.
    • (2006) Carcinogenesis , vol.27 , pp. 269-277
    • Lee, W.J.1    Zhu, B.T.2
  • 219
    • 25144507259 scopus 로고    scopus 로고
    • Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids
    • Lee, W.J.; Shim, J.Y.; Zhu, B.T. Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids. Mol. Pharmacol. 2005, 68, 1018-1030.
    • (2005) Mol. Pharmacol. , vol.68 , pp. 1018-1030
    • Lee, W.J.1    Shim, J.Y.2    Zhu, B.T.3
  • 221
    • 33845969839 scopus 로고    scopus 로고
    • Dietary polyphenols may affect DNA methylation
    • Fang, M.; Chen, D.; Yang, C.S. Dietary polyphenols may affect DNA methylation. J. Nutr. 2007, 137, 223S-228S.
    • (2007) J. Nutr. , vol.137
    • Fang, M.1    Chen, D.2    Yang, C.S.3
  • 222
    • 79952972082 scopus 로고    scopus 로고
    • New drug therapies in peripheral T-cell lymphoma
    • Howman, R.A.; Prince, H.M. New drug therapies in peripheral T-cell lymphoma. Expert Rev. Anticancer Ther. 2011, 11, 457-472.
    • (2011) Expert Rev. Anticancer Ther. , vol.11 , pp. 457-472
    • Howman, R.A.1    Prince, H.M.2
  • 225
    • 70349780606 scopus 로고    scopus 로고
    • The emerging therapeutic potential of histone methyltransferase and demethylase inhibitors
    • Spannhoff, A.; Hauser, A.T.; Heinke, R.; Sippl, W.; Jung, M. The emerging therapeutic potential of histone methyltransferase and demethylase inhibitors. Chem. Med. Chem. 2009, 4, 1568-1582.
    • (2009) Chem. Med. Chem. , vol.4 , pp. 1568-1582
    • Spannhoff, A.1    Hauser, A.T.2    Heinke, R.3    Sippl, W.4    Jung, M.5
  • 226
    • 84871674660 scopus 로고    scopus 로고
    • Inhibition of PRC2 histone methyltransferase activity increases TRAIL-mediated apoptosis sensitivity in human colon cancer cells
    • Benoit, Y.D.; Laursen, K.B.; Witherspoon, M.S.; Lipkin, S.M.; Gudas, L.J. Inhibition of PRC2 histone methyltransferase activity increases TRAIL-mediated apoptosis sensitivity in human colon cancer cells. J. Cell Physiol. 2013, 228, 764-772.
    • (2013) J. Cell Physiol. , vol.228 , pp. 764-772
    • Benoit, Y.D.1    Laursen, K.B.2    Witherspoon, M.S.3    Lipkin, S.M.4    Gudas, L.J.5
  • 227
    • 50249095068 scopus 로고    scopus 로고
    • Early phase II trial of oral vorinostat in relapsed or refractory breast, colorectal, or non-small cell lung cancer
    • Vansteenkiste, J.; van Cutsem, E.; Dumez, H.; Chen, C.; Ricker, J.L.; Randolph, S.S.; Schoffski, P. Early phase II trial of oral vorinostat in relapsed or refractory breast, colorectal, or non-small cell lung cancer. Invest. New Drugs 2008, 26, 483-488.
    • (2008) Invest. New Drugs , vol.26 , pp. 483-488
    • Vansteenkiste, J.1    van Cutsem, E.2    Dumez, H.3    Chen, C.4    Ricker, J.L.5    Randolph, S.S.6    Schoffski, P.7
  • 228
    • 84860327244 scopus 로고    scopus 로고
    • Decitabine and vorinostat cooperate to sensitize colon carcinoma cells to fas ligand-induced apoptosis in vitro and tumor suppression in vivo
    • Yang, D.; Torres, C.M.; Bardhan, K.; Zimmerman, M.; McGaha, T.L.; Liu, K. Decitabine and vorinostat cooperate to sensitize colon carcinoma cells to fas ligand-induced apoptosis in vitro and tumor suppression in vivo. J. Immunol. 2012, 188, 4441-4449.
    • (2012) J. Immunol. , vol.188 , pp. 4441-4449
    • Yang, D.1    Torres, C.M.2    Bardhan, K.3    Zimmerman, M.4    McGaha, T.L.5    Liu, K.6
  • 229
    • 0034614637 scopus 로고    scopus 로고
    • The hallmarks of cancer
    • Hanahan, D.; Weinberg, R.A. The hallmarks of cancer. Cell 2000, 100, 57-70.
    • (2000) Cell , vol.100 , pp. 57-70
    • Hanahan, D.1    Weinberg, R.A.2
  • 230
    • 17644419708 scopus 로고    scopus 로고
    • Impaired CD95 expression predisposes for recurrence in curatively resected colon carcinoma: Clinical evidence for immunoselection and CD95L mediated control of minimal residual disease
    • Strater, J.; Hinz, U.; Hasel, C.; Bhanot, U.; Mechtersheimer, G.; Lehnert, T.; Moller, P. Impaired CD95 expression predisposes for recurrence in curatively resected colon carcinoma: Clinical evidence for immunoselection and CD95L mediated control of minimal residual disease. Gut 2005, 54, 661-665.
    • (2005) Gut , vol.54 , pp. 661-665
    • Strater, J.1    Hinz, U.2    Hasel, C.3    Bhanot, U.4    Mechtersheimer, G.5    Lehnert, T.6    Moller, P.7
  • 231
    • 0032476609 scopus 로고    scopus 로고
    • Fas and Fas ligand interactions suppress melanoma lung metastasis
    • Owen-Schaub, L.B.; van Golen, K.L.; Hill, L.L.; Price, J.E. Fas and Fas ligand interactions suppress melanoma lung metastasis. J. Exp. Med. 1998, 188, 1717-1723.
    • (1998) J. Exp. Med. , vol.188 , pp. 1717-1723
    • Owen-Schaub, L.B.1    van Golen, K.L.2    Hill, L.L.3    Price, J.E.4
  • 232
    • 0028246885 scopus 로고
    • Expression of APO-1 (CD95), a member of the NGF/TNF receptor superfamily, in normal and neoplastic colon epithelium
    • Moller, P.; Koretz, K.; Leithauser, F.; Bruderlein, S.; Henne, C.; Quentmeier, A.; Krammer, P.H. Expression of APO-1 (CD95), a member of the NGF/TNF receptor superfamily, in normal and neoplastic colon epithelium. Int. J. Cancer 1994, 57, 371-377.
    • (1994) Int. J. Cancer , vol.57 , pp. 371-377
    • Moller, P.1    Koretz, K.2    Leithauser, F.3    Bruderlein, S.4    Henne, C.5    Quentmeier, A.6    Krammer, P.H.7
  • 233
    • 34249868241 scopus 로고    scopus 로고
    • Adoptive T cell therapy for cancer in the clinic
    • June, C.H. Adoptive T cell therapy for cancer in the clinic. J. Clin. Invest. 2007, 117, 1466-1476.
    • (2007) J. Clin. Invest. , vol.117 , pp. 1466-1476
    • June, C.H.1
  • 234
    • 84858758766 scopus 로고    scopus 로고
    • Adoptive immunotherapy for cancer: Harnessing the T cell response
    • Restifo, N.P.; Dudley, M.E.; Rosenberg, S.A. Adoptive immunotherapy for cancer: Harnessing the T cell response. Nat. Rev. Immunol. 2012, 12, 269-281.
    • (2012) Nat. Rev. Immunol. , vol.12 , pp. 269-281
    • Restifo, N.P.1    Dudley, M.E.2    Rosenberg, S.A.3
  • 236
    • 59149100185 scopus 로고    scopus 로고
    • IFN regulatory factor 8 sensitizes soft tissue sarcoma cells to death receptor-initiated apoptosis via repression of FLICE-like protein expression
    • Yang, D.; Wang, S.; Brooks, C.; Dong, Z.; Schoenlein, P.V.; Kumar, V.; Ouyang, X.; Xiong, H.; Lahat, G.; Hayes-Jordan, A.; et al. IFN regulatory factor 8 sensitizes soft tissue sarcoma cells to death receptor-initiated apoptosis via repression of FLICE-like protein expression. Cancer Res. 2009, 69, 1080-1088.
    • (2009) Cancer Res. , vol.69 , pp. 1080-1088
    • Yang, D.1    Wang, S.2    Brooks, C.3    Dong, Z.4    Schoenlein, P.V.5    Kumar, V.6    Ouyang, X.7    Xiong, H.8    Lahat, G.9    Hayes-Jordan, A.10
  • 237
    • 34548863369 scopus 로고    scopus 로고
    • Targeting lymphotoxin beta receptor with tumor-specific T lymphocytes for tumor regression
    • Yang, D.; Ud Din, N.; Browning, D.D.; Abrams, S.I.; Liu, K. Targeting lymphotoxin beta receptor with tumor-specific T lymphocytes for tumor regression. Clin. Cancer Res. 2007, 13, 5202-5210.
    • (2007) Clin. Cancer Res. , vol.13 , pp. 5202-5210
    • Yang, D.1    Ud Din, N.2    Browning, D.D.3    Abrams, S.I.4    Liu, K.5
  • 239
    • 0037869289 scopus 로고    scopus 로고
    • Role of hMLH1 promoter hypermethylation in drug resistance to 5-fluorouracil in colorectal cancer cell lines
    • Arnold, C.N.; Goel, A.; Boland, C.R. Role of hMLH1 promoter hypermethylation in drug resistance to 5-fluorouracil in colorectal cancer cell lines. Int. J. Cancer 2003, 106, 66-73.
    • (2003) Int. J. Cancer , vol.106 , pp. 66-73
    • Arnold, C.N.1    Goel, A.2    Boland, C.R.3
  • 240
    • 0038387494 scopus 로고    scopus 로고
    • 5-fluorouracil: Mechanisms of action and clinical strategies
    • Longley, D.B.; Harkin, D.P.; Johnston, P.G. 5-fluorouracil: Mechanisms of action and clinical strategies. Nat. Rev. Cancer 2003, 3, 330-338.
    • (2003) Nat. Rev. Cancer , vol.3 , pp. 330-338
    • Longley, D.B.1    Harkin, D.P.2    Johnston, P.G.3
  • 241
    • 0019277437 scopus 로고
    • Facilitated transport of uracil and 5-fluorouracil, and permeation of orotic acid into cultured mammalian cells
    • Wohlhueter, R.M.; McIvor, R.S.; Plagemann, P.G. Facilitated transport of uracil and 5-fluorouracil, and permeation of orotic acid into cultured mammalian cells. J. Cell Physiol. 1980, 104, 309-319.
    • (1980) J. Cell Physiol. , vol.104 , pp. 309-319
    • Wohlhueter, R.M.1    McIvor, R.S.2    Plagemann, P.G.3
  • 244
    • 0033783056 scopus 로고    scopus 로고
    • Mechanism of action of fluoropyrimidines: Relevance to the new developments in colorectal cancer chemotherapy
    • Sobrero, A.; Guglielmi, A.; Grossi, F.; Puglisi, F.; Aschele, C. Mechanism of action of fluoropyrimidines: Relevance to the new developments in colorectal cancer chemotherapy. Semin. Oncol. 2000, 27, 72-77.
    • (2000) Semin. Oncol. , vol.27 , pp. 72-77
    • Sobrero, A.1    Guglielmi, A.2    Grossi, F.3    Puglisi, F.4    Aschele, C.5
  • 245
    • 0015993325 scopus 로고
    • Structures of reversible and irreversible complexes of thymidylate synthetase and fluorinated pyrimidine nucleotides
    • Danenberg, P.V.; Langenbach, R.J.; Heidelberger, C. Structures of reversible and irreversible complexes of thymidylate synthetase and fluorinated pyrimidine nucleotides. Biochemistry 1974, 13, 926-933.
    • (1974) Biochemistry , vol.13 , pp. 926-933
    • Danenberg, P.V.1    Langenbach, R.J.2    Heidelberger, C.3
  • 246
    • 0015962412 scopus 로고
    • Mechanism of interaction of thymidylate synthetase with 5-fluorodeoxyuridylate
    • Santi, D.V.; McHenry, C.S.; Sommer, H. Mechanism of interaction of thymidylate synthetase with 5-fluorodeoxyuridylate. Biochemistry 1974, 13, 471-481.
    • (1974) Biochemistry , vol.13 , pp. 471-481
    • Santi, D.V.1    McHenry, C.S.2    Sommer, H.3
  • 248
    • 0028982818 scopus 로고
    • Ratio of 2'-deoxyadenosine-5'-triphosphate/thymidine-5'-triphosphate influences the commitment of human colon carcinoma cells to thymineless death
    • Houghton, J.A.; Tillman, D.M.; Harwood, F.G. Ratio of 2'-deoxyadenosine-5'-triphosphate/thymidine-5'-triphosphate influences the commitment of human colon carcinoma cells to thymineless death. Clin. Cancer Res. 1995, 1, 723-730.
    • (1995) Clin. Cancer Res. , vol.1 , pp. 723-730
    • Houghton, J.A.1    Tillman, D.M.2    Harwood, F.G.3
  • 249
    • 0023655202 scopus 로고
    • Deoxyribonucleoside triphosphate imbalance. 5-Fluorodeoxyuridine-induced DNA double strand breaks in mouse FM3A cells and the mechanism of cell death
    • Yoshioka, A.; Tanaka, S.; Hiraoka, O.; Koyama, Y.; Hirota, Y.; Ayusawa, D.; Seno, T.; Garrett, C.; Wataya, Y. Deoxyribonucleoside triphosphate imbalance. 5-Fluorodeoxyuridine-induced DNA double strand breaks in mouse FM3A cells and the mechanism of cell death. J. Biol. Chem. 1987, 262, 8235-8241.
    • (1987) J. Biol. Chem. , vol.262 , pp. 8235-8241
    • Yoshioka, A.1    Tanaka, S.2    Hiraoka, O.3    Koyama, Y.4    Hirota, Y.5    Ayusawa, D.6    Seno, T.7    Garrett, C.8    Wataya, Y.9
  • 250
    • 12144290775 scopus 로고    scopus 로고
    • Digital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patients
    • Wang, T.L.; Diaz, L.A., Jr.; Romans, K.; Bardelli, A.; Saha, S.; Galizia, G.; Choti, M.; Donehower, R.; Parmigiani, G.; Shih Ie, M.; et al. Digital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patients. Proc. Natl. Acad. Sci. USA 2004, 101, 3089-3094.
    • (2004) Proc. Natl. Acad. Sci. USA , vol.101 , pp. 3089-3094
    • Wang, T.L.1    Diaz Jr., L.A.2    Romans, K.3    Bardelli, A.4    Saha, S.5    Galizia, G.6    Choti, M.7    Donehower, R.8    Parmigiani, G.9    Shih Ie, M.10
  • 251
    • 55449094139 scopus 로고    scopus 로고
    • Copy-number analysis of topoisomerase and thymidylate synthase genes in frozen and FFPE DNAs of colorectal cancers
    • Yu, J.; Miller, R.; Zhang, W.; Sharma, M.; Holtschlag, V.; Watson, M.A.; McLeod, H.L. Copy-number analysis of topoisomerase and thymidylate synthase genes in frozen and FFPE DNAs of colorectal cancers. Pharmacogenomics 2008, 9, 1459-1466.
    • (2008) Pharmacogenomics , vol.9 , pp. 1459-1466
    • Yu, J.1    Miller, R.2    Zhang, W.3    Sharma, M.4    Holtschlag, V.5    Watson, M.A.6    McLeod, H.L.7
  • 253
    • 33750317308 scopus 로고    scopus 로고
    • Genomic copy number changes affecting the thymidylate synthase (TYMS) gene in cancer: A model for patient classification to aid fluoropyrimidine therapy
    • Brody, J.R.; Hucl, T.; Gallmeier, E.; Winter, J.M.; Kern, S.E.; Murphy, K.M. Genomic copy number changes affecting the thymidylate synthase (TYMS) gene in cancer: A model for patient classification to aid fluoropyrimidine therapy. Cancer Res. 2006, 66, 9369-9373.
    • (2006) Cancer Res. , vol.66 , pp. 9369-9373
    • Brody, J.R.1    Hucl, T.2    Gallmeier, E.3    Winter, J.M.4    Kern, S.E.5    Murphy, K.M.6
  • 254
    • 33847611097 scopus 로고    scopus 로고
    • Involvement of gene polymorphisms of thymidylate synthase in gene expression, protein activity and anticancer drug cytotoxicity using the NCI-60 panel
    • Nief, N.; Le Morvan, V.; Robert, J. Involvement of gene polymorphisms of thymidylate synthase in gene expression, protein activity and anticancer drug cytotoxicity using the NCI-60 panel. Eur. J. Cancer 2007, 43, 955-962.
    • (2007) Eur. J. Cancer , vol.43 , pp. 955-962
    • Nief, N.1    Le Morvan, V.2    Robert, J.3
  • 255
    • 0034192487 scopus 로고    scopus 로고
    • Levels of E2F-1 expression are higher in lung metastasis of colon cancer as compared with hepatic metastasis and correlate with levels of thymidylate synthase
    • Banerjee, D.; Gorlick, R.; Liefshitz, A.; Danenberg, K.; Danenberg, P.C.; Danenberg, P.V.; Klimstra, D.; Jhanwar, S.; Cordon-Cardo, C.; Fong, Y.; et al. Levels of E2F-1 expression are higher in lung metastasis of colon cancer as compared with hepatic metastasis and correlate with levels of thymidylate synthase. Cancer Res. 2000, 60, 2365-2367.
    • (2000) Cancer Res. , vol.60 , pp. 2365-2367
    • Banerjee, D.1    Gorlick, R.2    Liefshitz, A.3    Danenberg, K.4    Danenberg, P.C.5    Danenberg, P.V.6    Klimstra, D.7    Jhanwar, S.8    Cordon-Cardo, C.9    Fong, Y.10
  • 257
    • 65849197551 scopus 로고    scopus 로고
    • The chromatin remodeling factor CHD8 interacts with elongating RNA polymerase II and controls expression of the cyclin E2 gene
    • Rodriguez-Paredes, M.; Ceballos-Chavez, M.; Esteller, M.; Garcia-Dominguez, M.; Reyes, J.C. The chromatin remodeling factor CHD8 interacts with elongating RNA polymerase II and controls expression of the cyclin E2 gene. Nucleic Acids Res. 2009, 37, 2449-2460.
    • (2009) Nucleic Acids Res. , vol.37 , pp. 2449-2460
    • Rodriguez-Paredes, M.1    Ceballos-Chavez, M.2    Esteller, M.3    Garcia-Dominguez, M.4    Reyes, J.C.5
  • 258
    • 44049101802 scopus 로고    scopus 로고
    • Identification of predictive biomarkers for the histone deacetylase inhibitor belinostat in a panel of human cancer cell lines
    • Dejligbjerg, M.; Grauslund, M.; Christensen, I.J.; Tjornelund, J.; Buhl Jensen, P.; Sehested, M. Identification of predictive biomarkers for the histone deacetylase inhibitor belinostat in a panel of human cancer cell lines. Cancer Biomark. 2008, 4, 101-109.
    • (2008) Cancer Biomark. , vol.4 , pp. 101-109
    • Dejligbjerg, M.1    Grauslund, M.2    Christensen, I.J.3    Tjornelund, J.4    Buhl Jensen, P.5    Sehested, M.6
  • 259
    • 66849111560 scopus 로고    scopus 로고
    • Epigenetic reversal of acquired resistance to 5-fluorouracil treatment
    • Humeniuk, R.; Mishra, P.J.; Bertino, J.R.; Banerjee, D. Epigenetic reversal of acquired resistance to 5-fluorouracil treatment. Mol. Cancer Ther. 2009, 8, 1045-1054.
    • (2009) Mol. Cancer Ther. , vol.8 , pp. 1045-1054
    • Humeniuk, R.1    Mishra, P.J.2    Bertino, J.R.3    Banerjee, D.4
  • 261
    • 44349137412 scopus 로고    scopus 로고
    • SPARC promoter hypermethylation in colorectal cancers can be reversed by 5-Aza-2'deoxycytidine to increase SPARC expression and improve therapy response
    • Cheetham, S.; Tang, M.J.; Mesak, F.; Kennecke, H.; Owen, D.; Tai, I.T. SPARC promoter hypermethylation in colorectal cancers can be reversed by 5-Aza-2'deoxycytidine to increase SPARC expression and improve therapy response. Br. J. Cancer 2008, 98, 1810-1819.
    • (2008) Br. J. Cancer , vol.98 , pp. 1810-1819
    • Cheetham, S.1    Tang, M.J.2    Mesak, F.3    Kennecke, H.4    Owen, D.5    Tai, I.T.6
  • 262
    • 80155131161 scopus 로고    scopus 로고
    • Verticillin A overcomes apoptosis resistance in human colon carcinoma through DNA methylation-dependent upregulation of BNIP3
    • Liu, F.; Liu, Q.; Yang, D.; Bollag, W.B.; Robertson, K.; Wu, P.; Liu, K. Verticillin A overcomes apoptosis resistance in human colon carcinoma through DNA methylation-dependent upregulation of BNIP3. Cancer Res. 2011, 71, 6807-6816.
    • (2011) Cancer Res. , vol.71 , pp. 6807-6816
    • Liu, F.1    Liu, Q.2    Yang, D.3    Bollag, W.B.4    Robertson, K.5    Wu, P.6    Liu, K.7
  • 264
    • 84873033322 scopus 로고    scopus 로고
    • Chemotherapy and Radiotherapy Downregulate the Activity and Expression of DNA Methyltransferase and Enhance Bcl-2/E1B-19-kDa Interacting Protein-3-Induced Apoptosis in Human Colorectal Cancer Cells
    • Deng, Q.; Huang, C.M.; Chen, N.; Li, L.; Wang, X.D.; Zhang, W.; Bi, F.; Tang, Q.L.; Li, Z.P.; Wang, W. Chemotherapy and Radiotherapy Downregulate the Activity and Expression of DNA Methyltransferase and Enhance Bcl-2/E1B-19-kDa Interacting Protein-3-Induced Apoptosis in Human Colorectal Cancer Cells. Chemotherapy 2012, 58, 445-453.
    • (2012) Chemotherapy , vol.58 , pp. 445-453
    • Deng, Q.1    Huang, C.M.2    Chen, N.3    Li, L.4    Wang, X.D.5    Zhang, W.6    Bi, F.7    Tang, Q.L.8    Li, Z.P.9    Wang, W.10
  • 265
    • 68149172699 scopus 로고    scopus 로고
    • Modulation of thymidilate synthase and p53 expression by HDAC inhibitor vorinostat resulted in synergistic antitumor effect in combination with 5FU or raltitrexed
    • Di Gennaro, E.; Bruzzese, F.; Pepe, S.; Leone, A.; Delrio, P.; Subbarayan, P.R.; Avallone, A.; Budillon, A. Modulation of thymidilate synthase and p53 expression by HDAC inhibitor vorinostat resulted in synergistic antitumor effect in combination with 5FU or raltitrexed. Cancer Biol. Ther. 2009, 8, 782-791.
    • (2009) Cancer Biol. Ther. , vol.8 , pp. 782-791
    • di Gennaro, E.1    Bruzzese, F.2    Pepe, S.3    Leone, A.4    Delrio, P.5    Subbarayan, P.R.6    Avallone, A.7    Budillon, A.8
  • 267
    • 33846257239 scopus 로고    scopus 로고
    • Histone deacetylase inhibitor enhances 5-fluorouracil cytotoxicity by down-regulating thymidylate synthase in human cancer cells
    • Lee, J.H.; Park, J.H.; Jung, Y.; Kim, J.H.; Jong, H.S.; Kim, T.Y.; Bang, Y.J. Histone deacetylase inhibitor enhances 5-fluorouracil cytotoxicity by down-regulating thymidylate synthase in human cancer cells. Mol. Cancer Ther. 2006, 5, 3085-3095.
    • (2006) Mol. Cancer Ther. , vol.5 , pp. 3085-3095
    • Lee, J.H.1    Park, J.H.2    Jung, Y.3    Kim, J.H.4    Jong, H.S.5    Kim, T.Y.6    Bang, Y.J.7
  • 269
    • 67449089565 scopus 로고    scopus 로고
    • Histone deacetylase inhibitors suppress thymidylate synthase gene expression and synergize with the fluoropyrimidines in colon cancer cells
    • Fazzone, W.; Wilson, P.M.; Labonte, M.J.; Lenz, H.J.; Ladner, R.D. Histone deacetylase inhibitors suppress thymidylate synthase gene expression and synergize with the fluoropyrimidines in colon cancer cells. Int. J. Cancer 2009, 125, 463-473.
    • (2009) Int. J. Cancer , vol.125 , pp. 463-473
    • Fazzone, W.1    Wilson, P.M.2    Labonte, M.J.3    Lenz, H.J.4    Ladner, R.D.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.